The CD79B gene helps B cells, a type of white blood cell, sense germs and make a normal antibody response. The protein made by this gene forms part of the B cell receptor, which sends signals that guide B cell growth and activity. If the CD79B gene does not work properly, immune defenses may be weaker and the body may have trouble making antibodies. Some acquired variants in the CD79B gene are also linked to certain B cell lymphomas.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or to regulate processes in the body. Some genes provide the directions for producing proteins, which are the active components of cells. Others are mainly involved in controlling when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, and medications. More detailed information on this topic is available in the LearnHub.
Overview
CD79BGene function
What if the gene works
The CD79B gene helps build part of the B cell receptor, a sensor on immune cells. This helps B cells develop normally and send signals when they detect germs.
Risk
What if the gene does not work
More disruptive CD79B gene variants can cause a rare antibody deficiency with very low B cells and repeated infections from infancy. Milder variants may leave some immune function, so symptoms can start later and vary.
Treatment
What does that mean for your treatment
No CD79B-specific treatment or drug choice is currently established in clinical guidelines for people with a pathogenic variant in the CD79B gene. The CD79B gene is being studied as a biomarker and drug target in some B cell lymphomas, including whether certain variants may influence response to B cell receptor pathway drugs such as BTK inhibitors.
Conditions associated with CD79B
Gene function
What if the gene works
Your immune system depends on B cells to spot germs before they cause trouble. The CD79B gene helps these cells place their germ sensing receptor on the surface and pass along the signal when something binds. In daily life, this is how the CD79B gene helps B cells recognize germs and support antibody responses.
The CD79B gene helps B cells build and display their surface receptor, the sensor they use to detect germs. Its protein joins the receptor complex so it can sit in the cell membrane and work reliably.
When that receptor binds a target, CD79B helps carry the message from the cell surface to the inside of the B cell. This tells the cell that something has been recognized and that it should begin a controlled immune response.
These signals help guide normal B cell development and readiness as the immune system matures. They support the steps that let B cells survive, learn what to respond to, and later take part in making antibodies.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant changes how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CD79B gene can change how the protein folds, reaches the cell surface, or passes signals inside B cells. More disruptive variants may greatly reduce or stop signaling, while milder variants can leave some activity in place, which can influence how early and how strongly immune problems appear. Some CD79B gene variants, especially certain changes found in lymphoma cells, can also make signaling stay switched on longer than it should.
How variants are linked to conditions
Pathogenic variants in the CD79B gene can cause a rare inherited immune condition called agammaglobulinemia 6, in which very low antibody levels leave people prone to repeated bacterial infections. In cancer care, acquired, not inherited, CD79B gene variants are also linked to some B cell lymphomas, especially certain diffuse large B cell lymphomas and primary central nervous system lymphoma. These lymphoma associated changes do not mean a person was born with a CD79B related condition.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widespread in the general population. Most do not directly affect health and simply reflect natural human variation. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to the CD79B gene itself. Changes in CD79B are most often found in cancer cells rather than inherited, so personal risk usually depends more on the overall condition and other health factors than on this gene alone.
Inheritance of CD79B variants
Inherited CD79B-related disease is usually passed down in an autosomal recessive pattern. This means a child inherits one altered copy of the CD79B gene from each parent, while parents who carry one variant are often unaffected. For families asking how CD79B variants are inherited, when both parents are carriers, each pregnancy has a 25% chance of having a child with the condition, a 50% chance of having a carrier child, and a 25% chance of having a child without the familial variant. Because the CD79B gene is on chromosome 17, this pattern is the same for males and females.
What does my CD79B result mean for my family?
For the rare inherited immune condition linked to the CD79B gene, family members can sometimes carry the gene change even if they feel well. Brothers and sisters may also be affected or be carriers, and parents are often carriers. A CD79B change found only in cancer cells is usually not passed down, so the family meaning depends on what kind of result was found.
Genetic information
Genetic testing
How you find out about variants
To look for variants in the CD79B gene, CD79B genetic testing uses DNA from a blood sample, cheek swab, or sometimes tumor tissue. A lab reads the gene’s code and checks for changes, then reports whether a variant was found and whether it may help explain a diagnosis.
When should I consider getting a genetic test?
Genetic testing for the CD79B gene may be considered when someone has severe, repeated infections starting in infancy or childhood, especially if blood tests show very low antibody levels or a low number of infection-fighting B cells. It can also help when a close family member has a confirmed CD79B-related immune condition.
A genetic result is only one part of your health story
A genetic result can be very informative, but what it can tell you varies based on the condition and the kind of variant involved. Over time, many factors also shape how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target. This helps explain why the same treatment works well for one person, works less well for another, or causes more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics examines how inherited genetic differences affect a person’s response to medications. It studies connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body handles it. This information can support more informed, more individualized treatment decisions. More on this topic is available in the LearnHub.
Drugs influenced by the CD79B gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so general concerns about your health or medicines are best discussed with your doctor. In some B-cell lymphomas, changes in the CD79B gene are being studied because they may affect how well certain targeted cancer treatments work.
History
CD79B entered the research literature during studies of B cells in the late 1980s and early 1990s, when scientists were sorting out the proteins that sit alongside surface antibodies on these immune cells. It was first known as B29, and later work clarified its place in the CD79 family and standardized the name CD79B. From these first observations, research expanded steadily as immunology and molecular genetics linked CD79B to B cell signaling. Interest in the gene grew further when recurrent CD79B variants were identified in certain B cell lymphomas, especially diffuse large B cell lymphoma. That discovery helped move CD79B from a basic science finding into modern cancer research and diagnostic classification.